Please assess the completion status of the following clinical trial:

Trial Title: ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Per the current approved labeling for the Conformity European (CE) Marked MitraClip System.~Exclusion Criteria:~* Per the current approved labeling for the CE Marked MitraClip System.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MitraClip Therapy (Type: None): Patients treated with the MitraClip System.
- Medical Management (Type: None): Patients with MR managed non-surgically based on standard hospital clinical practice.
- Mitral Valve Surgery (Type: None): Patients with MR managed surgically (repair or replacement) based on standard hospital clinical practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).